INDIVIOR PHARMACEUTICALS INC (INDV) Stock Price, Forecast & Analysis
NASDAQ:INDV • US45579U1097
INDV Key Statistics, Chart & Performance
The current stock price of INDV is 33.76 USD. In the past month the price increased by 0.39%. In the past year, price increased by 243.44%.
INDV Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to INDV. When comparing the yearly performance of all stocks, INDV is one of the better performing stocks in the market, outperforming 98.21% of all stocks.
INDV Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to INDV. INDV has an excellent profitability rating, but there are some minor concerns on its financial health.
INDV Financial Highlights
Over the last trailing twelve months INDV reported a non-GAAP Earnings per Share(EPS) of 1.96. The EPS increased by 256.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 10.34% | ||
| ROA | 8.62% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
INDV Forecast & Estimates
13 analysts have analysed INDV and the average price target is 46.48 USD. This implies a price increase of 37.69% is expected in the next year compared to the current price of 33.76.
For the next year, analysts expect an EPS growth of 440.8% and a revenue growth 3.67% for INDV
INDV Ownership
INDV Latest News, Press Relases and Analysis
INDV Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 30.93 | 981.56B | ||
| JNJ | JOHNSON & JOHNSON | 20.99 | 589.194B | ||
| MRK | MERCK & CO. INC. | 22.04 | 295.956B | ||
| PFE | PFIZER INC | 9.15 | 156.186B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.84 | 121.86B | ||
| ZTS | ZOETIS INC | 18.29 | 55.368B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.64 | 25.86B | ||
| VTRS | VIATRIS INC | 6.24 | 18.186B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 23.71 | 12.317B | ||
| AXSM | AXSOME THERAPEUTICS INC | 223.38 | 9.222B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About INDV
Company Profile
Indivior Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Slough, Berkshire and currently employs 1,030 full-time employees. Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The firm sells its products in the United States and in other selected areas of the world.
Company Info
INDIVIOR PHARMACEUTICALS INC
234 Bath Road
SLOUGH BERKSHIRE US
Employees: 1030
Phone: 448043791090
INDIVIOR PHARMACEUTICALS INC / INDV FAQ
What does INDV do?
Indivior Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Slough, Berkshire and currently employs 1,030 full-time employees. Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The firm provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The firm sells its products in the United States and in other selected areas of the world.
What is the stock price of INDIVIOR PHARMACEUTICALS INC today?
The current stock price of INDV is 33.76 USD. The price decreased by -0.94% in the last trading session.
Does INDV stock pay dividends?
INDV does not pay a dividend.
How is the ChartMill rating for INDIVIOR PHARMACEUTICALS INC?
INDV has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the market cap for INDIVIOR PHARMACEUTICALS INC?
INDIVIOR PHARMACEUTICALS INC (INDV) has a market capitalization of 4.21B USD. This makes INDV a Mid Cap stock.
Can you provide the upcoming earnings date for INDIVIOR PHARMACEUTICALS INC?
INDIVIOR PHARMACEUTICALS INC (INDV) will report earnings on 2026-02-26, after the market close.
Can you provide the ownership details for INDV stock?
You can find the ownership structure of INDIVIOR PHARMACEUTICALS INC (INDV) on the Ownership tab.